AlanH.LaiMD

PubMed

• Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounti...
  Leu K, Boxerman JL, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB, Ellingson BM> ;AJNR Am J Neuroradiol. 2016-08-01
• Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma.
  Qiao XJ, Ellingson BM, Kim HJ, Wang DJJ, Salamon N, Linetsky M, Sepahdari AR, Jiang B, Tian JJ, Esswein SR, Cloughesy TF, Lai A, Nghiemphu L, Pope WB> ;AJNR Am J Neuroradiol. 2015-04-01
• Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.
  Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason WP, Cloughesy TF> ;AJNR Am J Neuroradiol. 2014-04-01
• Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls
  P L Nghiemphu, A Lai, T F Cloughesy> ;American Journal of Neuroradiology. 2012 Oct
• Probabilistic radiographic atlas of glioblastoma phenotypes.
  Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF> ;AJNR Am J Neuroradiol. 2013-03-01
• Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.
  Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Moftakhar P, Lalaezari S, Yong W, Ellingson BM, Cloughesy TF, Pope WB> ;AJNR Am J Neuroradiol. 2012-08-01
• Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
  Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, Ellingson B, Nghiemphu PL, Kharbanda S, Soriano RH, Nelson SF, Yong W, Phillips HS, Cloughesy TF> ;AJNR Am J Neuroradiol. 2012-06-01
• Prediction of GBM outcome using combined analysis of MGMT protein expression and promoter methylation.
  Lai A, Lalezari S, Chou AP, Tran A, Solis OE, Carrillo JA, Chen W, Mischel PS, Green RM, Nghiemphu PL, Liau LM, Wang H, Elashoff RM, Cloughesy TF, Yong WH> ;J. Clin. Oncol.. 2011-05-20
• Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.
  Pope WB, Lai A, Mehta R, Kim HJ, Qiao J, Young JR, Xue X, Goldin J, Brown MS, Nghiemphu PL, Tran A, Cloughesy TF> ;AJNR Am J Neuroradiol. 2011-05-01
• Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.
  Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R, Cloughesy TF> ;Neurology. 2009-04-07
• MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.
  Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF> ;Neurology. 2006-04-25
• Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods i...
  Cha S, Yang L, Johnson G, Lai A, Chen M, Tihan T, Wendland M, Dillon WP> ;AJNR Am J Neuroradiol. 2006-02-01
• The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats.
  Thulborn KR, Sorensen AG, Kowall NW, McKee A, Lai A, McKinstry RC, Moore J, Rosen BR, Brady TJ> ;AJR Am J Roentgenol. 1990-05-01
• The role of ferritin and hemosiderin in the MR appearance of cerebral hemorrhage: a histopathologic biochemical study in rats.
  Thulborn KR, Sorensen AG, Kowall NW, McKee A, Lai A, McKinstry RC, Moore J, Rosen BR, Brady TJ> ;AJNR Am J Neuroradiol. 1990-01-01
• Join now to see all